326 related articles for article (PubMed ID: 22001099)
1. Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Moro C; Uchiyama J; Chess-Williams R
Urology; 2011 Dec; 78(6):1442.e9-15. PubMed ID: 22001099
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Ohtake A; Saitoh C; Yuyama H; Ukai M; Okutsu H; Noguchi Y; Hatanaka T; Suzuki M; Sato S; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
[TBL] [Abstract][Full Text] [Related]
3. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
Kobayashi S; Ikeda K; Miyata K
Life Sci; 2004 Jan; 74(7):843-53. PubMed ID: 14659973
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of tolterodine on human isolated urinary bladder.
Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
Ohtake A; Ukai M; Hatanaka T; Kobayashi S; Ikeda K; Sato S; Miyata K; Sasamata M
Eur J Pharmacol; 2004 May; 492(2-3):243-50. PubMed ID: 15178371
[TBL] [Abstract][Full Text] [Related]
7. Contractile activity of the bladder urothelium/lamina propria and its regulation by nitric oxide.
Moro C; Leeds C; Chess-Williams R
Eur J Pharmacol; 2012 Jan; 674(2-3):445-9. PubMed ID: 22119378
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
Salcedo C; Davalillo S; Cabellos J; Lagunas C; Balsa D; Pérez-Del-Pulgar S; Ballarín M; Fernández A
Br J Pharmacol; 2009 Mar; 156(5):807-17. PubMed ID: 19222482
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
10. Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium/lamina propria of the pig bladder.
Moro C; Chess-Williams R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):53-9. PubMed ID: 22994938
[TBL] [Abstract][Full Text] [Related]
11. On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder.
Giglio D; Delbro DS; Tobin G
Eur J Pharmacol; 2001 Oct; 428(3):357-64. PubMed ID: 11689195
[TBL] [Abstract][Full Text] [Related]
12. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
13. M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro.
Sellers DJ; Yamanishi T; Chapple CR; Couldwell C; Yasuda K; Chess-Williams R
J Auton Pharmacol; 2000 Jun; 20(3):171-6. PubMed ID: 11193006
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [3H]acetylcholine in the rabbit urinary bladder.
Tobin G; Sjögren C
Eur J Pharmacol; 1995 Jul; 281(1):1-8. PubMed ID: 8566107
[TBL] [Abstract][Full Text] [Related]
15. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder.
Braverman AS; Tibb AS; Ruggieri MR
J Pharmacol Exp Ther; 2006 Feb; 316(2):869-74. PubMed ID: 16243961
[TBL] [Abstract][Full Text] [Related]
16. Regulation of bladder muscarinic receptor subtypes by experimental pathologies.
Ruggieri MR; Braverman AS
Auton Autacoid Pharmacol; 2006 Jul; 26(3):311-25. PubMed ID: 16879497
[TBL] [Abstract][Full Text] [Related]
17. M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.
Braverman AS; Lebed B; Linder M; Ruggieri MR
Neurourol Urodyn; 2007; 26(1):63-70. PubMed ID: 17123299
[TBL] [Abstract][Full Text] [Related]
18. Role of M2 and M3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats.
Matsumoto Y; Miyazato M; Yokoyama H; Kita M; Hirao Y; Chancellor MB; Yoshimura N
Urology; 2012 May; 79(5):1184.e15-20. PubMed ID: 22386753
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Naruganahalli KS; Sinha S; Hegde LG; Meru AV; Chugh A; Kumar N; Gupta JB; Ray A
Eur J Pharmacol; 2007 Oct; 572(2-3):207-12. PubMed ID: 17610864
[TBL] [Abstract][Full Text] [Related]
20. Adrenoceptor function and expression in bladder urothelium and lamina propria.
Moro C; Tajouri L; Chess-Williams R
Urology; 2013 Jan; 81(1):211.e1-7. PubMed ID: 23200975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
